Leonardo Tamariz, MD, MPH
Articles by Leonardo Tamariz, MD, MPH

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?
ByAna Palacio, MD, MPH,Ruaa Mansi, MD, MPH,David Seo, MD,Maritza Suarez, MD,Sylvia Garay, MD,Heidy Medina, MPH,Fei Tang, PhD,Leonardo Tamariz, MD, MPH Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.

High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population
ByReyan Ghany, MD,Leonardo Tamariz, MD, MPH,Gordon Chen, MD,Elissa Dawkins, MS,Alina Ghany, MD,Emancia Forbes, RDCS,Thiago Tajiri, MBA,Ana Palacio, MD, MPH Evaluating the impact of a high-touch primary care model among a Medicare Advantage population in comparison with a standard practice–based model.
Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.

Impact of a Physician-Led Point of Care Medication Delivery System on Medication Adherence
ByAna Palacio, MD, MPH,Jessica Chen, MD,Leonardo Tamariz, MD, MPH,Sylvia D. Garay, MD,Hua Li, PhD,Olveen Carrasquillo, MD, MPH A point of care medication delivery system improves medication adherence to cardiovascular medications without increasing costs.

The Use of Claims Data Algorithms to Recruit Eligible Participants Into Clinical Trials
ByLeonardo Tamariz, MD, MPH,Ana Palacio, MD, MPH,Jennifer Denizard, RN,Yvonne Schulman, MD,Gabriel Contreras, MD, MPH Using an ICD-9-CM code algorithm, the authors effectively identified potentially difficult-to-reach populations for a hypertension clinical trial.

Impact of Certified CME in Atrial Fibrillation on Administrative Claims
ByStephanie A. Stowell, MPhil,Allison J. Gardner, PhD,Joseph S. Alpert, MD,Gerald V. Naccarelli, MD,Thomas P. Harkins, MA, MPH,Anthony M. Louder, PhD, RPh,Leonardo Tamariz, MD, MPH Use of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.

Persistence With Biologic Therapies in the Medicare Coverage Gap
ByLeonardo Tamariz, MD, MPH,Claudia L. Uribe, MD, PhD,Jiacong Luo, MD, MPH,John W. Hanna, MBA,Daniel E. Ball, DrPH,Kelly Krohn, MD,Eric S. Meadows, PhD For patients who reached the Medicare Part D coverage gap, discontinuation was more likely for patients taking osteoporosis medication.